阿摩線上測驗
67 下列何者不是腎臟癌之腫瘤伴隨症候群（paraneoplastic syndromes）？
(A)紅血球增多症（erythrocytosis）
(B)低血鈣症（hypocalcemia）
(C)高血壓
(D)非轉移性肝功能異常（Stauffer’s syndrome）
答案：登入後查看
統計： A(12), B(48), C(3), D(6), E(0) #1047606
統計： A(12), B(48), C(3), D(6), E(0) #1047606
詳解 (共 3 筆)
MORRIS M114
#4473309
醫學五：80題 ( 包括外科,骨科,泌尿科等科目及其相關臨床實例與醫學倫理 )- 96 年 - 096年第一次專門職業及技術人員高等暨普通醫事人員、中醫師、心理師、呼吸治療師、營養師、獸醫人員暨醫師分試（第一試）醫師#38982
答案：B,C
65 下列有關腎細胞癌（renal cell carcinoma）之敘述，何者正確？
(A)腎細胞癌源自腎臟之 distal renal tubule 上皮
(B)結節性硬化（tuberous sclerosis）與腎細胞癌有關
(C)腎細胞癌常伴隨腫瘤旁症候群（paraneoplastic syndrome）
(D)腎細胞癌對化學藥物治療之反應很好
0
0
Chris
#3954914
Hypercalcemia — Hypercalcemia occurs in up to 15 percent of patients with advanced RCC and can result from a number of different mechanisms:
●Lytic bone metastases.
●Overproduction of PTHrP [20-23]. Concurrent production of IL-6 may enhance the action of PTHrP [24,25].
●Increased production of prostaglandins that promote bone resorption [26,27]. In such patients, the hypercalcemia can respond to administration of a nonsteroidal anti-inflammatory drug (NSAID), such as indomethacin [26].
●Lytic bone metastases.
●Overproduction of PTHrP [20-23]. Concurrent production of IL-6 may enhance the action of PTHrP [24,25].
●Increased production of prostaglandins that promote bone resorption [26,27]. In such patients, the hypercalcemia can respond to administration of a nonsteroidal anti-inflammatory drug (NSAID), such as indomethacin [26].
0
0